Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Programmed Cell Death 1 Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07740941
What this trial is testing

NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma

Who this might be right for
Melanoma (Skin Cancer)Melanoma Stage Stage IIIBMelanoma Stage M1+1 more
UNC Lineberger Comprehensive Cancer Center 55
Not applicableStudy completedNCT06024356
What this trial is testing

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer

Who this might be right for
Colorectal Neoplasms
Beijing Friendship Hospital 47
Early research (Phase 1)Study completedNCT03790488
What this trial is testing

Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies

Who this might be right for
Cancer
Jounce Therapeutics, Inc. 18
Large-scale testing (Phase 3)Not Yet RecruitingNCT06089382
What this trial is testing

Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection

Who this might be right for
Hepatocellular Carcinoma
Tongji Hospital 104
Testing effectiveness (Phase 2)UnknownNCT04483219
What this trial is testing

Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma.

Who this might be right for
MSSpMMRMetastatic Colorectal Adenocarcinoma
China Medical University, China 53
Large-scale testing (Phase 3)Study completedNCT04924062
What this trial is testing

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension Study

Who this might be right for
Biliary Tract Carcinoma
Merck Sharp & Dohme LLC 158
Testing effectiveness (Phase 2)UnknownNCT04156698
What this trial is testing

Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma

Who this might be right for
Hypopharyngeal CarcinomaImmunotherapyChemotherapy
Eye & ENT Hospital of Fudan University 51
Not applicableStudy completedNCT04253080
What this trial is testing

Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors

Who this might be right for
Cutaneous Melanoma
Assistance Publique - Hôpitaux de Paris 127
Large-scale testing (Phase 3)Not Yet RecruitingNCT06089369
What this trial is testing

Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion

Who this might be right for
Hepatocellular Carcinoma
Tongji Hospital 360
Large-scale testing (Phase 3)Ended earlyNCT03348904
What this trial is testing

Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Incyte Corporation 2
Testing effectiveness (Phase 2)Study completedNCT03612791
What this trial is testing

Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab

Who this might be right for
Locally Advanced Cervical Cancer
Gustave Roussy, Cancer Campus, Grand Paris 189
Testing effectiveness (Phase 2)Active Not RecruitingNCT05271318
What this trial is testing

Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer.

Who this might be right for
Platinum-refractory Ovarian CarcinomaPlatinum-resistant Ovarian CancerPlatinum-Resistant Fallopian Tube Carcinoma+6 more
TILT Biotherapeutics Ltd. 29
Testing effectiveness (Phase 2)Study completedNCT03797326
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

Who this might be right for
Advanced Solid TumorsTriple Negative Breast CancerOvarian Cancer+5 more
Merck Sharp & Dohme LLC 611
Testing effectiveness (Phase 2)Study completedNCT04995419
What this trial is testing

Evaluate Enfortumab Vedotin (ASG-22CE) in Chinese Participants With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Platinum-containing Chemotherapy and Programmed Cell Death Protein-1 ( PD 1) / (Programmed Death Ligand-1 (PD-L1) Inhibitor Therapy

Who this might be right for
Metastatic Urothelial Cancer
Astellas Pharma China, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT04740307
What this trial is testing

Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)

Who this might be right for
Advanced Hepatocellular Carcinoma
Merck Sharp & Dohme LLC 116
Early research (Phase 1)Looking for participantsNCT07161414
What this trial is testing

Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

Who this might be right for
Advanced Solid Tumors
AstraZeneca 40
Testing effectiveness (Phase 2)Study completedNCT02306850
What this trial is testing

Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma

Who this might be right for
Unresectable Malignant NeoplasmMelanomaMetastatic Melanoma+2 more
St. Louis University 10
Not applicableUnknownNCT06364046
What this trial is testing

Efficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLC

Who this might be right for
CarcinomaSmall Cell Lung Cancer
The Central Hospital of Lishui City 56
Not applicableUnknownNCT05123287
What this trial is testing

A Perspective, Self-control Study on the Progression of Carotid Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up

Who this might be right for
Plaque, AtheroscleroticImmune Checkpoint InhibitorsProgrammed Cell Death Protein 1 Inhibitor+2 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT00882869
What this trial is testing

XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma
Aegera Therapeutics 75
Next Page